University of Texas MD Anderson Cancer Center
Form 483 issued March 24, 2022 · Houston, Texas
- Inspection
- Mar 16 – Mar 24, 2022
- Observations
- 1
- Pages
- 3
- FEI number
- 3010547404
In short: On March 24, 2022, FDA issued a Form 483 with 1 observation to University of Texas MD Anderson Cancer Center in Houston, Texas (FEI 3010547404) after an inspection that ran Mar 16 – Mar 24, 2022. Most observations concern production; the most-cited regulation is 21 CFR 211.115 (reprocessing).
At a glance
1 of 1 observations on this 483 concern production.
Most cited: 21 CFR 211.115(a) (1×)
What FDA observed
Preview: the opening words of each observation- 01
Procedures prescribing a system for reprocessing batches to insure that the reprocessed batches will conform with…
This inspection in context
Questions about this 483
What did FDA find at University of Texas MD Anderson Cancer Center?
FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.115 (reprocessing). The opening words of each observation are shown on this page.
When was University of Texas MD Anderson Cancer Center inspected by FDA?
The inspection ran Mar 16 – Mar 24, 2022, and the Form 483 is dated March 24, 2022.
How do I get the full Form 483 for University of Texas MD Anderson Cancer Center?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.